P95 | Not an infection, but a complication of antibiotic therapy: daptomycin acute eosinophilic pneumonia
Abstract
Background: Daptomycin therapy is a leading cause of acute eosinophilic pneumonia (AEP), a rare but significant condition in Internal Medicine. It can manifest as acute respiratory failure, fever, and eosinophilia.
Case report: Patient is a 78 years old woman admitted for antibiotic treatment of MSSA sepsis complicated by osteomyelitis, prosthetic aortic valve endocarditis, and lung abscesses. She was treated with daptomycin 700 mg/day and ceftaroline 600 mg x 3. Following the removal of the prosthetic valve, clinical improvement was observed, with a decrease in fever, leukocytosis, CRP/PCT, and improved respiratory function.After one week of antibiotic therapy, an increase in eosinophil count (19.6%, 2360/µL) and CRP levels (2 ->25 mg/dL) was noted. Due to suspicion of an allergic reaction, empiric steroid therapy was initiated. Bacterial, fungal, and helminthic infections were ruled out. Bronchoalveolar lavage revealed 81% of eosinophils.The patient experienced acute dyspnea, respiratory failure and fever during the night, which required NIMV. A CT scan showed multifocal pneumonia with both interstitial honeycombing and consolidations. Based on these findings, a diagnosis of AEP was made. Steroids were increased (methylprednisolone 1 mg/kg/day) and daptomycin was discontinued. Over the next three days, there was a rapid improvement which allowed for the suspension of NIMV and reduction of consolidations seen on the chest X-ray. Normalization of the eosinophil count was observed after just two day of steroid therapy. A chest X-ray performed one week later documented complete resolution of the AEP.
Metrics
Citations and online attention from Dimensions, Altmetric and PlumX.
License
Copyright (c) 2025 the Author(s)

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.